Sara Jasak

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

R. Geocadin, J. Claassen, C. Falo, 2019, The Lancet Neurology.

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Thalia Shoshana Field, Eric E. Smith, Stacy D. Brown, 2020, The Lancet.

Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2)

William B. Jones, S. Mayer, A. Alexandrov, 2016, Stroke.

Minority Patients are Less Likely to Undergo Withdrawal of Care After Spontaneous Intracerebral Hemorrhage

C. Langefeld, D. Woo, K. Sheth, 2018, Neurocritical Care.

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Thalia Shoshana Field, Eric E. Smith, Stacy D. Brown, 2020, Lancet.